<?xml version='1.0' encoding='utf-8'?>
<document id="22173281"><sentence text="Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir."><entity charOffset="53-64" id="DDI-PubMed.22173281.s1.e0" text="venlafaxine" /><entity charOffset="82-91" id="DDI-PubMed.22173281.s1.e1" text="indinavir" /><entity charOffset="96-110" id="DDI-PubMed.22173281.s1.e2" text="desvenlafaxine" /><entity charOffset="128-137" id="DDI-PubMed.22173281.s1.e3" text="indinavir" /><pair ddi="false" e1="DDI-PubMed.22173281.s1.e0" e2="DDI-PubMed.22173281.s1.e0" /><pair ddi="false" e1="DDI-PubMed.22173281.s1.e0" e2="DDI-PubMed.22173281.s1.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s1.e0" e2="DDI-PubMed.22173281.s1.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s1.e0" e2="DDI-PubMed.22173281.s1.e3" /><pair ddi="false" e1="DDI-PubMed.22173281.s1.e1" e2="DDI-PubMed.22173281.s1.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s1.e1" e2="DDI-PubMed.22173281.s1.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s1.e1" e2="DDI-PubMed.22173281.s1.e3" /><pair ddi="false" e1="DDI-PubMed.22173281.s1.e2" e2="DDI-PubMed.22173281.s1.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s1.e2" e2="DDI-PubMed.22173281.s1.e3" /></sentence><sentence text="To assess the effects of venlafaxine extended-release (XR) capsules and desvenlafaxine extended-release (XR) tablets upon indinavir pharmacokinetic properties when co-administrated to healthy volunteers"><entity charOffset="25-36" id="DDI-PubMed.22173281.s2.e0" text="venlafaxine" /><entity charOffset="72-86" id="DDI-PubMed.22173281.s2.e1" text="desvenlafaxine" /><entity charOffset="122-131" id="DDI-PubMed.22173281.s2.e2" text="indinavir" /><pair ddi="false" e1="DDI-PubMed.22173281.s2.e0" e2="DDI-PubMed.22173281.s2.e0" /><pair ddi="false" e1="DDI-PubMed.22173281.s2.e0" e2="DDI-PubMed.22173281.s2.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s2.e0" e2="DDI-PubMed.22173281.s2.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s2.e1" e2="DDI-PubMed.22173281.s2.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s2.e1" e2="DDI-PubMed.22173281.s2.e2" /></sentence><sentence text="" /><sentence text="This was an open-label, two-period, fixed-dose study conducted at the clinical research unit located on a university campus" /><sentence text=" Twenty-four healthy volunteers enrolled in the study (mean age 28" /><sentence text="3 Â± 8" /><sentence text="0 years)" /><sentence text=" Each subject received a single dose of indinavir 800 mg on day 1"><entity charOffset="40-49" id="DDI-PubMed.22173281.s8.e0" text="indinavir" /></sentence><sentence text=" Subsequently, subjects were then randomly assigned to either the venlafaxine XR group (N = 12) or the desvenlafaxine XR group (N = 12)"><entity charOffset="66-77" id="DDI-PubMed.22173281.s9.e0" text="venlafaxine" /><entity charOffset="88-89" id="DDI-PubMed.22173281.s9.e1" text="N" /><entity charOffset="103-117" id="DDI-PubMed.22173281.s9.e2" text="desvenlafaxine" /><entity charOffset="128-129" id="DDI-PubMed.22173281.s9.e3" text="N" /><pair ddi="false" e1="DDI-PubMed.22173281.s9.e0" e2="DDI-PubMed.22173281.s9.e0" /><pair ddi="false" e1="DDI-PubMed.22173281.s9.e0" e2="DDI-PubMed.22173281.s9.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s9.e0" e2="DDI-PubMed.22173281.s9.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s9.e0" e2="DDI-PubMed.22173281.s9.e3" /><pair ddi="false" e1="DDI-PubMed.22173281.s9.e1" e2="DDI-PubMed.22173281.s9.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s9.e1" e2="DDI-PubMed.22173281.s9.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s9.e1" e2="DDI-PubMed.22173281.s9.e3" /><pair ddi="false" e1="DDI-PubMed.22173281.s9.e2" e2="DDI-PubMed.22173281.s9.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s9.e2" e2="DDI-PubMed.22173281.s9.e3" /></sentence><sentence text=" Starting on day 2, venlafaxine XR was dosed at 37" /><sentence text="5 mg/day for 4 days and increased to 75 mg/day for 6 days" /><sentence text=" Desvenlafaxine XR was dosed at 50 mg/day for 10 days"><entity charOffset="1-15" id="DDI-PubMed.22173281.s12.e0" text="Desvenlafaxine" /></sentence><sentence text=" On day 12, indivanvir 800 mg was co-administered to both the venlafaxine XR and the desvenlafaxine XR groups"><entity charOffset="62-73" id="DDI-PubMed.22173281.s13.e0" text="venlafaxine" /><entity charOffset="85-99" id="DDI-PubMed.22173281.s13.e1" text="desvenlafaxine" /><pair ddi="false" e1="DDI-PubMed.22173281.s13.e0" e2="DDI-PubMed.22173281.s13.e0" /><pair ddi="false" e1="DDI-PubMed.22173281.s13.e0" e2="DDI-PubMed.22173281.s13.e1" /></sentence><sentence text=" The pharmacokinetics of indinavir were determined both before and at the end of antidepressant dosing"><entity charOffset="25-34" id="DDI-PubMed.22173281.s14.e0" text="indinavir" /></sentence><sentence text=" Plasma indinavir, venlafaxine, and desvenlafaxine concentrations were assayed by high-performance liquid chromatography with ultra-violet (UV) detection"><entity charOffset="8-17" id="DDI-PubMed.22173281.s15.e0" text="indinavir" /><entity charOffset="19-30" id="DDI-PubMed.22173281.s15.e1" text="venlafaxine" /><entity charOffset="36-50" id="DDI-PubMed.22173281.s15.e2" text="desvenlafaxine" /><pair ddi="false" e1="DDI-PubMed.22173281.s15.e0" e2="DDI-PubMed.22173281.s15.e0" /><pair ddi="false" e1="DDI-PubMed.22173281.s15.e0" e2="DDI-PubMed.22173281.s15.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s15.e0" e2="DDI-PubMed.22173281.s15.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s15.e1" e2="DDI-PubMed.22173281.s15.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s15.e1" e2="DDI-PubMed.22173281.s15.e2" /></sentence><sentence text=" Indinavir pharmacokinetic parameters were calculated by noncompartmental analysis using validated computer software"><entity charOffset="1-10" id="DDI-PubMed.22173281.s16.e0" text="Indinavir" /></sentence><sentence text="" /><sentence text="Venlafaxine XR and desvenlafaxine XR did not produce any significant changes in indinavir disposition"><entity charOffset="0-11" id="DDI-PubMed.22173281.s18.e0" text="Venlafaxine" /><entity charOffset="19-33" id="DDI-PubMed.22173281.s18.e1" text="desvenlafaxine" /><entity charOffset="80-89" id="DDI-PubMed.22173281.s18.e2" text="indinavir" /><pair ddi="false" e1="DDI-PubMed.22173281.s18.e0" e2="DDI-PubMed.22173281.s18.e0" /><pair ddi="false" e1="DDI-PubMed.22173281.s18.e0" e2="DDI-PubMed.22173281.s18.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s18.e0" e2="DDI-PubMed.22173281.s18.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s18.e1" e2="DDI-PubMed.22173281.s18.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s18.e1" e2="DDI-PubMed.22173281.s18.e2" /></sentence><sentence text=" Both antidepressants were well tolerated by the subjects with only minor adverse side effects" /><sentence text="" /><sentence text="No pharmacokinetic drug-drug interaction was demonstrated between venlafaxine XR and indinavir or between desvenlafaxine XR and indinvair"><entity charOffset="66-77" id="DDI-PubMed.22173281.s21.e0" text="venlafaxine" /><entity charOffset="85-94" id="DDI-PubMed.22173281.s21.e1" text="indinavir" /><entity charOffset="106-120" id="DDI-PubMed.22173281.s21.e2" text="desvenlafaxine" /><entity charOffset="0-13" id="DDI-PubMed.22173281.s21.e3" text="N" /><pair ddi="false" e1="DDI-PubMed.22173281.s21.e3" e2="DDI-PubMed.22173281.s21.e3" /><pair ddi="false" e1="DDI-PubMed.22173281.s21.e3" e2="DDI-PubMed.22173281.s21.e0" /><pair ddi="false" e1="DDI-PubMed.22173281.s21.e3" e2="DDI-PubMed.22173281.s21.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s21.e3" e2="DDI-PubMed.22173281.s21.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s21.e0" e2="DDI-PubMed.22173281.s21.e0" /><pair ddi="false" e1="DDI-PubMed.22173281.s21.e0" e2="DDI-PubMed.22173281.s21.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s21.e0" e2="DDI-PubMed.22173281.s21.e2" /><pair ddi="false" e1="DDI-PubMed.22173281.s21.e1" e2="DDI-PubMed.22173281.s21.e1" /><pair ddi="false" e1="DDI-PubMed.22173281.s21.e1" e2="DDI-PubMed.22173281.s21.e2" /></sentence><sentence text=" The lack of interaction could be due to the venlafaxine and desvenlafaxine extended-release formulation"><entity charOffset="45-56" id="DDI-PubMed.22173281.s22.e0" text="venlafaxine" /><entity charOffset="61-75" id="DDI-PubMed.22173281.s22.e1" text="desvenlafaxine" /><pair ddi="false" e1="DDI-PubMed.22173281.s22.e0" e2="DDI-PubMed.22173281.s22.e0" /><pair ddi="false" e1="DDI-PubMed.22173281.s22.e0" e2="DDI-PubMed.22173281.s22.e1" /></sentence><sentence text="" /></document>